Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Classified in: Ebola virus, Health, Covid-19 virusSubject: PER Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax’s transition…